Homeopathic medicines specialist King Bio enacts nationwide recall

pharmafile | August 24, 2018 | News story | Medical Communications asheville, homeopathy, king bio, nc, recall 

The Asheville-based drug maker King Bio is recalling 32 children’s medicines because of potential ‘microbial contamination’.

The homeopathic medicines specialist is enacting a nationwide recall of a number of products produced between August 2017 and April 2018 which tested positive for microbial contamination. While no reports of illness have been made as of yet, the company stated that the recall was being made “out of an abundance of caution”.

Various medicines used for the treatment of common illnesses including fever, cough, cold and flu remedies are being recalled.

In light of the recall FDA commissioner Dr Scott Gottlieb tweeted that “While the King Bio homeopathic products recalled are due to a potential microbial contamination issue, products labeled as homeopathic have not been reviewed by the #FDA for safety and effectiveness”.

He added that “We respect that people may choose to use homeopathic products, but #FDA has a public health responsibility to protect consumers from products that may not deliver any benefit and have the potential to cause harm”

Homeopathy is a system of alternative medicine created by German physician Samuel Hahnemann in 1796. Large scale studies have found homeopathic treatments to be no more effective than placebo. The pseudoscientific practice puts forward that dilution increases potency. However pharmacological research has found that increased dosage induces stronger effects.

Louis Goss

Related Content


Nostrum Laboratories recalls metformin tablets over safety concerns

Missouri-based Nostrum Laboratories has issued a product recall of its type 2 diabetes drug metformin …


Sun Pharma issues recall of its generic diabetes drug in US market

Sun Pharma is recalling 747 bottles of its generic diabetes drug Riomet ER in the …

Pfizer recall two batches of migraine drug Relpax

Pfizer has recalled two lots of its migraine drug Relpax over concerns about microbiological contamination. …

Latest content